Investigational Drug May Combat Brain Tumors By Targeting Cancer Cells' Fat Production
The oral drug is currently being evaluated in phase I clinical trials for Parkinson’s disease.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
CONTACT INFORMATION
Yawkey 9E
55 Fruit Street
Boston,
MA
02114
Appointments
Schedule by calling: 617-726-6245
Prior to your first appointment, ask your primary care physician or referring doctor to fax pertinent medical records to the office.
Fax Number: 617-726-2424
Translation services are available. Please inform us if you need the assistance of a translator.
If you are a new patient to Mass General:
Call to obtain a registration number: 866-211-6588
What to bring to your appointment:
As a patient in our multidisciplinary Facial Pain Clinic, you may expect to receive medical treatment with medication management from our neurologists or orofacial pain specialists, surgical procedures from our neurosurgeon or oral surgeon, interventional treatment from our pain physician.
For health care provides who are interested in referring their patients, a faxed referral can be sent to 617-726-2424. If you are referring a patient for management for trigeminal neuralgia, a recent MRI of the brain with trigeminal protocol is recommended. If you have any questions regarding a referral, please call 617-726-6245. Our nurse practitioner will help to answer your questions.
Department of Neurology
Department of Neurosurgery
Department of Surgery, Oral & Maxillofacial Surgery, Orofacial Pain Service
Department of Surgery, Oral & Maxillofacial Surgery, Orofacial Pain Service
Department of Surgery, Oral & Maxillofacial Surgery, TMJ Surgery and Minimally Invasive TMJ Endoscopy
Department of Anesthesia, Critical Care and Pain Medicine
Department of Anesthesia, Critical Care and Pain Medicine
Department of Radiation Oncology
Clinical Program Lead, Multidisciplinary Facial Pain Clinic
Jennifer Cheng, CNP is a pain fellowship trained and certified nurse practitioner with an extensive background in both inpatient and outpatient headache and facial pain treatment. She has a clinical practice with the Department of Neurology Headache and Neuropathic Pain Unit.
Mass General is the #1 hospital in New England based U.S. News & World Report Best Hospitals for 2022-2023.
The oral drug is currently being evaluated in phase I clinical trials for Parkinson’s disease.
A growing body of literature supports the use of tenecteplase (TNK) for intravenous thrombolysis to restore perfusion for patients with acute ischemic stroke.
In a recent paper, a team of scientists led by Mass General's Elizabeth Klerman, MD, PhD, calls for more research to understand the neurophysiological changes in the brain that occur during the circadian night.
The brain of a woman who should have developed a fatal inherited form of Alzheimer's disease in her 40s but remained healthy into her 70s is offering important clues about the disease.
Technology looks for pieces of tumor cells’ genetic material that are circulating in the blood.
New study offers the first evidence of replay during sleep in the human motor cortex, which governs voluntary movement.
You can join other patients and families in making an impact and spreading awareness for the multidisciplinary Facial Pain Clinic. Philanthropic support is crucial in continuing our mission to improve the understanding and management of facial pain and enhance quality of life for our patients. There are many ways to get involved, from hosting an event, raising money through a race, or marking an occasion with gifts.